4
Changes in Ownership
Axogen, Inc. Filed Acc 0000805928-24-000047
Chief R&D Officer sold 6,881 shares at $7.68 ($52,846)
- Chief R&D Officer acquired 27,906 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Scopelianos Angelo · Chief R&D Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-16 | Exercise or conversion : show line 1 in the form | +21,281 | 58,250 | D | ||
| 2024-03-21 | Sale : show line 2 in the form | −5,251 | $7.68 | $40,328 | 52,999 | D |
| 2024-03-16 | Exercise or conversion : show line 3 in the form | +4,125 | 57,124 | D | ||
| 2024-03-21 | Sale : show line 4 in the form | −1,020 | $7.68 | $7,834 | 56,104 | D |
| 2024-03-21 | Exercise or conversion : show line 5 in the form | +2,500 | 58,604 | D | ||
| 2024-03-21 | Sale : show line 6 in the form | −610 | $7.68 | $4,685 | 57,994 | D |
| Open-market sales · 6,881 sh · avg $7.68 · $52,846 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-16 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −21,281 | 21,282 | D |
| 2024-03-16 | Exercise or conversion : show line 8 in the form Restricted Stock Units | −4,125 | 4,125 | D |
| 2024-03-16 | Exercise or conversion : show line 9 in the form Restricted Stock Units | −2,500 | 0 | D |
Loading xslF345X05/wk-form4_1711417017.xml…